Skip to main content
. 2010 Jul 5;29(36):5032–5047. doi: 10.1038/onc.2010.250

Figure 1.

Figure 1

Downregulation of ARRDC3 is an early event in carcinogenesis. Oncomine was used to analyze previously published microarray data. (a) Levels of ARRDC3 mRNA are decreased in human breast cancers when compared with normal breast tissue. (b) ARRDC3 mRNA levels decrease in human mammary epithelial cells after transformation with various oncogenes. (c) Levels of ARRDC3 mRNA are decreased in metastatic lesions when compared with the primary tumor in the same patient. (d) Expression of ARRDC3 mRNA is decreased in the initial ER+ tumors from patients that have relapsed when compared with 5-year disease-free patients. All data, including P-values, were calculated from Oncomine.